Alverine-d5 citrate

• CAT Number: S000257
• CAS Number: 1215327-00-6
• Molecular Formula: C26H30D5NO7
• Molecular Weight: 478.59
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: 2-hydroxypropane-1,2,3-tricarboxylic acid;N-(1,1,2,2,2-pentadeuterioethyl)-3-phenyl-N-(3-phenylpropyl)propan-1-amine
• InChI: InChI=1S/C20H27N.C6H8O7/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-8,11-14H,2,9-10,15-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/i1D3,2D2
• InChIKey: RYHCACJBKCOBTJ-LUIAAVAXSA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])N(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

Alverine-d5 citrate (CAS: 1215327-00-6), a premium pharmaceutical research compound designed for advanced gastrointestinal studies. As a deuterated analog of Alverine citrate, it offers enhanced stability and improved pharmacokinetic properties. Alverine-d5 citrate is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for irritable bowel syndrome (IBS) and other gastrointestinal disorders. Trusted by leading laboratories, Alverine-d5 citrate is your go-to solution for cutting-edge gastrointestinal research. Unlock new possibilities in GI treatment with Alverine-d5 citrate, where innovation meets reliability.

Reference

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[Content Brief]